Sinequan
In brief
- Sinequan (doxepin) is a prescription-only medicine (Rx) in Australia and most major markets; it is supplied through pharmacies and as generics—obtain via a valid prescription from a doctor. (Be aware some sellers may claim to supply without a receipt, but this is not legal or safe and is not recommended.)
- Sinequan is used for depression and anxiety and, at low doses (Silenor), for insomnia. It is a tricyclic antidepressant that non‑selectively inhibits the reuptake of serotonin and noradrenaline and has strong H1 antihistamine (sedative) effects.
- Usual dosages: depression/anxiety typical start 75 mg/day (divided or at bedtime), usual 75–150 mg/day, with maxima reported up to 300 mg/day; for insomnia (Silenor) 3–6 mg at bedtime. Elderly and hepatic/renal impairment require lower starting doses; not recommended for children under 12.
- Oral administration: capsules (commonly 10, 25, 50, 75, 100 mg), oral solution (10 mg/mL) and low‑dose tablets (3 mg, 6 mg for Silenor).
- Onset: sedative effects can be felt within 30–60 minutes; antidepressant effects typically take 1–3 weeks of regular treatment to become apparent.
- Duration of action: sedative/night‑time effect usually lasts through the night (around 6–8 hours); therapeutic antidepressant effect is maintained with daily dosing—doxepin’s elimination half‑life is roughly in the order of about 15–18 hours (varies by individual).
- Alcohol warning: avoid alcohol—concurrent use increases drowsiness, sedation and the risk of respiratory depression, falls and orthostatic hypotension.
- The most common side effect is drowsiness (sedation); other frequent effects include dry mouth, dizziness, blurred vision, constipation, urinary retention and weight gain.
- Would you like to try sinequan without a prescription?
Critical Warnings, Restrictions And Patient Protection (Australia)
Basic Sinequan Information
- INN (International Nonproprietary Name): Doxepin
- Brand Names Available In Australia: Doquel (Aspen) — capsules 10–100 mg
- ATC Code: N06AA12
- Forms & Dosages: Capsules 10, 25, 50, 75, 100 mg; oral solution 10 mg/mL (some markets); tablets 3 mg, 6 mg (Silenor internationally)
- Manufacturers In Australia: Aspen supplies Doquel; generics supplied globally by Mylan and Teva
- Registration Status In Australia: Registered as prescription only (Rx)
- OTC / Rx Classification: Prescription only (Rx)
Safety-First Summary For Australian Patients
If you are prescribed doxepin, speak to your prescriber or pharmacist before starting or stopping it and keep their contact details easy to find.
Doxepin is prescription-only under the Therapeutic Goods Administration and may be subject to PBS rules for subsidy eligibility.
In Australia, Doquel is the brand supplied locally and generics from Mylan and Teva are available.
Do not take doxepin if you have narrow‑angle glaucoma, urinary retention, known hypersensitivity to tricyclic antidepressants, or have used an MAOI in the last 14 days.
Older people and those with cardiac disease require specialist review before use due to increased risk of adverse effects.
Overdose can cause severe drowsiness, confusion, cardiac arrhythmias and seizures — seek immediate emergency care.
For suspected overdose call Triple Zero (000) or the Poisons Information Centre on 13 11 26.
- Contraindications: Narrow-angle glaucoma; urinary retention; TCA hypersensitivity; MAOI use within 14 days.
- Emergency contacts: Triple Zero (000); Poisons Information Centre 13 11 26.
- Before You Start — Quick Screening: Current medications (especially MAOIs, QT‑prolonging drugs), known heart disease, pregnancy or breastfeeding, and alcohol use.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Elderly patients are more sensitive to anticholinergic and sedative effects and should start at lower doses.
For depression the elderly may start around 25–50 mg/day and titrate cautiously while monitoring for confusion, falls and urinary problems.
Pregnancy and breastfeeding: avoid doxepin unless the expected benefit justifies the potential risk; consult an obstetrician and psychiatrist.
Hepatic or renal impairment requires dose reduction and closer monitoring because metabolism and excretion are altered.
- Risk Group → Key Concerns
- Elderly → Falls, confusion, anticholinergic burden.
- Pregnancy/Breastfeeding → Specialist risk–benefit discussion.
- Hepatic/Renal Impairment → Reduced clearance; lower starting dose.
- Cardiac Disease → Conduction abnormalities, arrhythmia risk.
- Monitoring Checklist: Baseline ECG if cardiac risk, LFTs, renal function, falls risk assessment and regular review for anticholinergic side effects.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Doxepin commonly causes drowsiness, dizziness and blurred vision so do not drive or operate heavy machinery until you know how you react.
Employers and occupational health must consider safety duties where a worker takes sedating medicines.
Alcohol and other sedatives increase impairment and should be avoided while initiating or changing dose of doxepin.
- Do Not Do → Drive, operate heavy machinery, work at heights, or perform safety‑critical tasks until unimpaired.
| Medication Effect | Workplace Implication |
|---|---|
| Drowsiness / slowed reactions | Unsafe for safety‑critical roles; inform occupational health if required |
| Blurred vision | Affects driving and tasks requiring fine visual acuity |
| Orthostatic hypotension | Increased fall and injury risk, especially in older workers |
Q&A — Can I Drive After Taking It In Australia?
Short answer: No until you know how it affects you.
Drowsiness and slowed reactions are common; follow the medication warning and NSW/VIC road safety guidance if impaired.
Impaired driving can have legal and insurance consequences if it contributes to an incident.
Usage Basics — Name, Brands And Legal Status In Australia
INN, Australian Brands And Packaging Notes
The international nonproprietary name (INN) is doxepin, often prescribed as doxepin hydrochloride in clinical notes.
In Australia the equivalent branded product is Doquel supplied by Aspen and commonly available as capsules 10–100 mg.
Generics from Mylan and Teva supply doxepin capsules in many markets and may be available locally.
Silenor tablets 3–6 mg are an internationally used low‑dose formulation for insomnia but are not the same Australian packaging as Doquel.
| Brand | Supplier | Forms |
|---|---|---|
| Doquel | Aspen | Capsules 10–100 mg |
| Generic Doxepin | Mylan, Teva | Capsules 10–100 mg |
| Silenor (international) | — | Tablets 3 mg, 6 mg (insomnia use) |
Legal Classification (TGA Approval, PBS Listing)
Doxepin is prescription-only under the TGA and requires a valid prescription for supply in Australia.
PBS listing varies by indication and formulation; many generics may be PBS‑subsidised for depression while low‑dose use for insomnia can be off‑label and may not attract PBS subsidy.
- What To Bring To The Pharmacy: paper or e‑prescription, Medicare card, current medication list, and any PBS authority paperwork.
Dosing Guide (Standard Regimens And Special Populations)
Standard Adult Dosing And Insomnia Regimen
For adults with depression and anxiety a commonly cited starting dose is 75 mg/day, given as a divided dose or at night.
The usual therapeutic range is 75–150 mg/day with doses up to 300 mg/day used in specialist settings under close supervision.
For insomnia, low‑dose doxepin (Silenor internationally) is used at 3–6 mg at bedtime rather than antidepressant doses.
| Indication | Starting Dose | Usual Range | Maximum |
|---|---|---|---|
| Depression / Anxiety | 75 mg/day | 75–150 mg/day | Up to 300 mg/day |
| Insomnia (low dose) | 3 mg at bedtime | 3–6 mg nightly | Not specified |
Dose Adjustments For Comorbidities And Age
Children under 12 are not recommended to take doxepin and adolescents require specialist oversight.
Elderly patients should start at the lower end such as 25–50 mg/day and increase slowly while monitoring for anticholinergic effects, falls and confusion.
Hepatic or renal impairment requires dose reduction and careful titration because of altered metabolism and excretion.
Patients with cardiac disease should have ECG monitoring before dose escalation because of conduction and arrhythmia risks.
- Dose Adjustment Triggers: advanced age, liver or renal impairment, interacting medicines, cardiac conduction issues.
Q&A — What If I Miss A Dose?
Take the missed dose as soon as you remember unless it is close to the next scheduled dose.
Do not double up to make up for missed doses and contact your prescriber or pharmacist if you miss multiple doses.
If you suspect overdose, seek emergency care immediately.
Interaction Chart — Foods, Drinks And Common Drug Conflicts
Alcohol, Caffeine And Australian Diet Contexts
Alcohol potentiates the sedative and orthostatic effects of doxepin and should be avoided while initiating and titrating therapy.
Caffeine does not have a direct pharmacological interaction but can worsen anxiety or insomnia symptoms for some people.
In hot and humid parts of Australia, anticholinergic effects may increase dehydration risk so advise fluid intake and heat precautions.
- Avoid Or Limit: Alcohol, excessive caffeine when experiencing anxiety, drugs that cause anticholinergic effects.
| Substance | Impact |
|---|---|
| Alcohol | Increased sedation and risk of falls |
| Caffeine | May aggravate anxiety or insomnia |
| Anticholinergic herbs/supplements | Added dry mouth, constipation, urinary retention |
Major Drug–Drug Interactions To Check (Clinically Important)
Concurrent MAOI use within 14 days is an absolute contraindication due to severe or life‑threatening interactions.
Be cautious with other QT‑prolonging medicines, other TCAs, strong CYP‑interacting drugs, anticholinergics, CNS depressants and serotonergic agents.
| Common Interacting Drugs | Recommended Action |
|---|---|
| MAOIs | Do not co‑prescribe; allow 14‑day washout |
| Other TCAs / anticholinergics | Increased anticholinergic burden; consider alternatives |
| QT‑prolonging drugs (certain antipsychotics, antiarrhythmics) | Review ECG and avoid combinations when possible |
| CNS depressants / alcohol | Increased sedation; advise avoidance |
- Always Check With Pharmacist: new prescription or over‑the‑counter meds, herbal supplements, recent MAOI use, and a history of arrhythmias.
User Reports & Trends (Australian Patient Feedback)
Patients on Australian forums and review sites commonly report sedation at therapeutic doses and dry mouth as frequent side effects.
Low‑dose doxepin is often praised for sleep improvement where other agents failed, while many switch to SSRIs for antidepressant tolerability.
Rural patients report limited specialist access and often rely on pharmacists for counselling and timely supply.
- Common Positives: Improved sleep at low dose, effective for mood in some patients, generic availability and lower cost compared with some options.
- Common Negatives: Sedation, dry mouth, constipation, weight gain and occasional dizziness or orthostatic symptoms.
A simple bar‑chart for patient use might show sedation, dry mouth and constipation as the most frequently reported side effects, with sleep improvement a commonly reported benefit.
Access & Purchase Options In Australia
Major Pharmacy Chains And Rural Access Differences
Major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart can routinely dispense doxepin when presented with a valid prescription.
Smaller community pharmacies in rural areas may need extra time to order stock — allow additional lead time for fills in remote locations.
As noted above, Aspen supplies Doquel locally and generics from Mylan and Teva may be stocked by pharmacies.
- How To Obtain: valid prescription (paper or e‑script), Medicare card for PBS claims, bring a current medication list and any PBS authority paperwork.
| Setting | Typical Turnaround |
|---|---|
| City Pharmacy (chain) | Same day to 48 hours |
| Rural Community Pharmacy | 48 hours to several days (may require order) |
In our online pharmacy, sinequan is available without a prescription, with discreet delivery to Australia in 9-21 days.
Online Pharmacies And Telehealth E‑Prescriptions
Australian telehealth services can issue e‑prescriptions for doxepin when clinically appropriate and a registered prescriber conducts the consult.
Ensure the telehealth provider is legitimate and that prescriptions are sent to an accredited Australian pharmacy for supply.
- Red Flags When Buying Online: overseas sellers offering no‑prescription supply, prices that appear too low to be genuine, lack of Australian contact details.
- Questions Pharmacist Will Ask: indication, current medicines, allergies, cardiac history, pregnancy/breastfeeding status and recent MAOI use.
Mechanism Of Action & Pharmacology (Patient-Friendly + Clinical Terms)
Simple Explanation For Patients
Doxepin is a tricyclic antidepressant that blocks the reuptake of noradrenaline and serotonin.
It also strongly blocks histamine H1 receptors and has anticholinergic effects, which explains both sedation and side effects like dry mouth and constipation.
- Mechanism → Effect → Clinical Implication
- Noradrenaline/serotonin reuptake inhibition → Mood improvement → Antidepressant benefit over weeks.
- H1 blockade → Sedation → Useful for sleep at low doses but impairs driving.
- Anticholinergic action → Dry mouth, constipation, urinary retention → Monitor especially in elderly.
Clinical Pharmacology Notes For Clinicians
High affinity for histamine H1 receptors causes pronounced sedation, which low‑dose formulations exploit for insomnia with minimal antidepressant dosing.
Doxepin is metabolised hepatically and interactions via cytochrome P450 should be considered in polypharmacy.
- Monitoring Parameters: ECG in patients with cardiac risk, LFTs as clinically indicated, renal function monitoring for dose adjustments, and review for anticholinergic load.
Indications & Off‑Label Uses In Australian Practice
TGA-Approved Indications And Common Clinical Applications
Doxepin is used for depression and anxiety spectrum disorders consistent with tricyclic antidepressant indications.
Low‑dose doxepin (Silenor internationally) is used for insomnia, but in Australia low‑dose use may be off‑label depending on the formulation supplied.
| Indication | Typical Dosing | PBS Status |
|---|---|---|
| Depression / Anxiety | 75–150 mg/day (starting 75 mg) | Often PBS‑subsidised for approved indications |
| Insomnia (low dose) | 3–6 mg at bedtime (Silenor) | May be off‑label in Australia depending on formulation |
Off‑Label Uses And Caution Areas
Off‑label uses include low‑dose insomnia management and occasionally neuropathic pain, although evidence is mixed and specialist input is recommended.
- When To Consider Off‑Label Use: failure of first‑line alternatives, specialist recommendation, informed consent and close monitoring for side effects and withdrawal risk.
Key Clinical Findings & Evidence (Recent Studies 2022–2026)
Systematic reviews and guideline updates continue to show SSRIs are preferred first‑line antidepressants because of better tolerability compared with TCAs.
Doxepin retains a role for patients who respond to TCAs or where low‑dose sedative properties are desired for insomnia.
- Top 3 Clinical Takeaways:
- SSRIs generally preferred first line for depression due to tolerability.
- Doxepin useful for treatment‑resistant cases and where sedative benefit is required.
- Cardiac and anticholinergic risks limit use in the elderly and those with cardiac disease.
For clinicians, include a short trials table in practice notes summarising trial author, year, population and main outcomes when discussing options with colleagues.
Alternatives Matrix (Comparisons And Pros/Cons)
PBS-Listed Alternatives Comparison Table
| Drug | Efficacy | Side-Effect Burden | Sedation | Anticholinergic Effects | PBS Status |
|---|---|---|---|---|---|
| Doxepin | Effective (TCA class) | Moderate–high | High | High | Generics may be PBS‑subsidised |
| Amitriptyline | Effective (TCA) | Moderate–high | High | High | PBS available |
| Nortriptyline | Effective; possibly better tolerated than amitriptyline | Moderate | Moderate | Moderate | PBS available |
| SSRIs (Sertraline, Fluoxetine) | Effective; first line | Lower than TCAs | Low–moderate | Low | PBS widely available |
- When To Choose Doxepin: prior good response to TCAs, need for sedative effect at night, cost or PBS considerations favouring a TCA.
Pros And Cons Checklist For Clinicians And Patients
- Pros: effective antidepressant, useful sedative properties at low dose, generic availability and long clinical experience.
- Cons: anticholinergic effects, cardiac risks, sedation, and a narrow therapeutic index in overdose.
Consider a brief decision flowchart in clinical notes: assess indication → check cardiac risk and meds → consider SSRI first line → consider doxepin if TCA indicated or insomnia benefit required.
Common Questions (Pharmacy Consultation FAQs)
- When Will I Feel Better? Mood effects often take 1–3 weeks to begin; full benefit may take longer.
- What Side Effects Should I Expect? Drowsiness, dry mouth, constipation, dizziness and weight change are common; report rash or abnormal behaviour promptly.
- Is It Addictive? Not habit‑forming, but do not stop abruptly — tapering reduces withdrawal symptoms.
- How Should I Store It? Store at room temperature 15–30°C in original packaging and protect from moisture and heat.
- Missed Dose? Take as soon as remembered unless near the next dose; do not double up.
- Overdose? Call Triple Zero (000) or Poisons Information 13 11 26 immediately.
Price & Access Comparison
Typical Price Ranges And PBS Subsidy Notes
| Pharmacy / Source | Typical Cash Price (AUD) | PBS Subsidy | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Varies; often competitive | Possible for generics on PBS | Yes |
| Independent City Pharmacy | Moderate | Possible | Yes |
| Rural Community Pharmacy | May be higher due to supply | Possible | Yes |
- How To Reduce Cost: use PBS where eligible, request a generic brand, compare pharmacies for best price and ask about concession entitlements.
Registration & Regulation (TGA, PBS, And Prescribing Rules)
TGA Approval And Prescription Controls
Doxepin is TGA‑regulated and prescription-only in Australia, and some PBS items may require authority prescriptions.
Importing doxepin from overseas without TGA approval is not permitted except through the Special Access Scheme or authorised channels.
- Prescribe → Supply → PBS Claim
- Prescriber issues script → Pharmacy dispenses after clinical check → PBS claimed if patient eligible and item listed.
- Definitions
- TGA — Therapeutic Goods Administration.
- PBS — Pharmaceutical Benefits Scheme.
- Authority Prescription — PBS requirement for special approval to obtain subsidy.
Storage, Handling And Pharmacy Logistics (Australian Climate)
Household Storage And Transport Advice
Store doxepin at room temperature 15–30°C and protect from moisture and excessive heat.
Advise patients not to leave medicines in hot cars or exposed to direct sunlight, especially in summer, and to carry in original packaging when travelling.
- At‑Home Storage Checklist: cool dry place, child‑resistant container, avoid bathrooms, check expiry dates and return expired stock to pharmacy for disposal.
| Pharmacy Cold-Chain | Requirement |
|---|---|
| Doxepin | Not cold‑chain; stable at room temperature |
Pharmacy Stock Management And Cold-Chain Notes
Doxepin capsules are stable but pharmacies should monitor stock, use accredited suppliers and allow lead times for rural orders.
- Inventory Best Practice: rotate stock by expiry, record batch numbers, order from Aspen or recognised distributors, and plan for seasonal demand.
Practical Guidelines For Proper Use (Pharmacist Counselling & Patient Actions)
Pharmacist Counselling Checklist (Australian Style)
Counselling should cover indication, dosing schedule and expected onset of effect.
Explain common side effects clearly: drowsiness, dry mouth, constipation, blurred vision and urinary retention.
Advise on driving safety, alcohol avoidance, interactions with MAOIs and QT‑prolonging drugs, and what to do in overdose.
- Provide: written information, document counselling in the patient record and arrange follow‑up with the prescriber.
- When To Seek Urgent Care: severe drowsiness, chest pain, fainting, seizures or signs of allergic reaction.
Follow-Up And Deprescribing Guidance
Arrange review within 2–4 weeks after initiation to assess efficacy and tolerability and to check for adverse effects.
Consider ECG before dose escalation in patients with cardiac risk factors.
Taper gradually when discontinuing to minimise withdrawal symptoms and coordinate deprescribing with the prescriber.
- Timeline Checklist: Initiate → Review at 2 weeks → Review at 4 weeks → Ongoing periodic review every 3 months or as clinically indicated.
- Taper Steps: reduce dose slowly over weeks to months depending on dose and duration of therapy; document plan in shared care records.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 14-21 days |
| Newcastle | New South Wales | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Toowoomba | Queensland | 14-21 days |